人类白细胞抗原G蛋白表达是肝细胞癌治愈性切除后的一种不良预后因子

2010-09-09 MedSci原创 MedSci原创

MedSci简评:这篇文章中上海中山医院肝癌研究所的文章,文章并不复杂,主要研究HLA-G对肝癌预后的判断。特色有:(1)选择的是肝癌治愈性切除后的样本;(2)采用了组织芯片技术;(3)样本量较大;(4)研究切入当前的热点如Treg作用。 Human leukocyte antigen-G protein expression is an unfavorable prognostic predi

MedSci简评:这篇文章中上海中山医院肝癌研究所的文章,文章并不复杂,主要研究HLA-G对肝癌预后的判断。特色有:(1)选择的是肝癌治愈性切除后的样本;(2)采用了组织芯片技术;(3)样本量较大;(4)研究切入当前的热点如Treg作用。

Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection

Cai MY, Xu YF, Qiu SJ, Ju MJ, Gao Q, Li YW, Zhang BH, Zhou J, Fan J

Clin Cancer Res. 2009 Jul 15;15(14):4686-93.

Purpose: Human leukocyte antigen-G (HLA-G) is a tumor-associated immunosuppressive molecule involved in tumor escape mechanisms. The aimof this study is to elucidate its prognostic significance in hepatocellular carcinoma (HCC). Experimental Design: Immunohistochemical staining of HLA-G expression as well as tumor infiltrating FoxP3+ regulatory( Tregs) and CD8 + cytotoxic T cells was carried out on tissue microarrays containing 173 HCC tissue specimens. Membrane-bound HLA-G1 protein expression in five human HCC cell lines was detected by Western blot. Results: HLA-G expression was associated with HCC prognosis, especially in early-stage diseases, with high expression independentlya ssociated with shortened overall survival (P = 0.041) and increased tumor recurrence (P = 0.023). HLA-G level was positivelyr elated to Tregs/CD8+ ratio and their combination served as a better prognosticator, patients having concurrent high levels of both variables at more than three times of risk of death and tumor relapse than those with concurrent lowlevels (both P < 0.001). In addition, HLA-G1 expression increased in a concordant manner with the increase of metastatic potential in human HCC cell lines. Conclusions: Overexpression of HLA-G protein in HCC was an independent indicator for poor outcome especially in early-stage disease. The combination of HLA-G expression and Tregs/CD8+ ratio added the prognostic power to both variables, offering a possible strategy of tumor-stroma interaction-oriented cancer immunotherapy. © 2009 American Association for Cancer Research.
Correspondence Address: Fan, J.; Institute of Biomedical Sciences, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China; email:jiafan99@yahoo.com

PDF全文下载.pdf

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]
    2010-10-31 lqvr
  2. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]
    2011-05-13 xjy02
  5. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]
    2010-09-11 xuyu
  7. [GetPortalCommentsPageByObjectIdResponse(id=1910942, encodeId=f89a1910942f2, content=<a href='/topic/show?id=1cad1001e728' target=_blank style='color:#2F92EE;'>#预后因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100177, encryptionId=1cad1001e728, topicName=预后因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sun Oct 31 23:09:00 CST 2010, time=2010-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1978294, encodeId=0a9b19e829498, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77978, encryptionId=3b90e79787f, topicName=细胞癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e457184, createdName=qingting, createdTime=Wed Feb 23 08:09:00 CST 2011, time=2011-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1715520, encodeId=ea481e155209e, content=<a href='/topic/show?id=b1f58362e8' target=_blank style='color:#2F92EE;'>#G蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8362, encryptionId=b1f58362e8, topicName=G蛋白)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a331951491, createdName=12498f1em18(暂无昵称), createdTime=Mon Nov 08 11:09:00 CST 2010, time=2010-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863173, encodeId=c0c718631e32d, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Fri May 13 18:09:00 CST 2011, time=2011-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1336313, encodeId=84e21336313b9, content=<a href='/topic/show?id=071820530c5' target=_blank style='color:#2F92EE;'>#不良预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20530, encryptionId=071820530c5, topicName=不良预后)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532644, encodeId=38771532644b6, content=<a href='/topic/show?id=f33388695c2' target=_blank style='color:#2F92EE;'>#蛋白表达#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88695, encryptionId=f33388695c2, topicName=蛋白表达)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d79512374813, createdName=xuyu, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623200, encodeId=346d16232004f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55263, encryptionId=62a655263e9, topicName=抗原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f59b20519025, createdName=xiaoyeshuang, createdTime=Sat Sep 11 06:09:00 CST 2010, time=2010-09-11, status=1, ipAttribution=)]